June 1, 2026 · Form 4 insider transaction
Anderson Kenneth Carl bought 1,070 shares of C4 Therapeutics, Inc. at $2.11 per share, a transaction worth $2.3K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 3 days after the transaction.
The reported transaction represents the exercise of a stock option for cash. No shares were sold in connection with the exercise.